$290M Settlement Reached In Related Valeant Insider Trading Suits

(January 3, 2018, 11:41 AM EST) -- SANTA ANA, Calif. — Defendants in a pair of related securities class action lawsuits alleging an insider-trading and front-running scheme regarding pharmaceutical company Valeant Pharmaceuticals International Inc.’s attempt at a hostile...
To view the full article, register now.